Estrella Immunopharma Inc...

NASDAQ: ESLA · Real-Time Price · USD
0.91
0.05 (5.76%)
At close: Aug 15, 2025, 3:59 PM
0.89
-1.70%
After-hours: Aug 15, 2025, 04:12 PM EDT

Estrella Immunopharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Feb 28, 2021
Net Income
-5.54M -2.1M -1.05M -3.38M -3.95M -469.53K -1.02M -1.87M -76K -63.33K -2.76M -344.86K -1.07M -168.29K -135.8K -107.55K -3.56K -819
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.49K -29.47K n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
159.1K 159.09K n/a n/a n/a n/a n/a 1.19M n/a 102.4K 102.4K n/a 34.13K 60.98K n/a n/a n/a n/a
Other Working Capital
4.98M 1.47M -278.03K 1.15M 3.66M -3.69M -985.77K 396.15K -22.95K -84.9K -46.51K -64K 12.9K -15.2K -156.65K 92.13K n/a n/a
Other Non-Cash Items
n/a n/a 432.26K n/a n/a 77.08K 9.26M 1.19M -114.31K -105.79K 8.98K -304.36K -164.63K -6.69K -857 -571 -2.5K n/a
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a 598.00 -21.7K 29.47K n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
4.97M 1.48M -278.03K 1.16M 3.66M -3.77M -10.25M 400.65K -22.95K -84.9K 2.54M 36.05K 113.35K -12.2K -156.65K 92.13K n/a n/a
Operating Cash Flow
-414.88K -465.98K -896.07K -2.22M -291.51K -4.23M -11.27M -275.19K -212.67K -275.72K -108.2K -513.13K -926.67K -107.31K -293.3K -15.98K -6.05K -819
Capital Expenditures
n/a n/a -4 n/a 3.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a -136.53K -136.53K n/a n/a n/a n/a n/a -42M -3.19M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a 157.96K 214.31K 36.17M n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a n/a n/a 5.07M -112.3K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a n/a n/a 5.07M -112.3K 21.43K 77.77K 36.17M n/a n/a n/a n/a -42M -3.19M n/a
Debt Repayment
n/a n/a n/a n/a -10M n/a -300K 10.3M 196.53K 186.53K n/a n/a n/a n/a n/a 120K -220K n/a
Common Stock Repurchased
121K -29.46K -64.01K -150.47K -270.35K -84.09K -5.07M n/a n/a n/a -36.11M n/a n/a n/a n/a -25K n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-40K n/a n/a -150.47K 9.73M n/a -1.53M -9.27M n/a n/a 50K 498.6K 15K 107.31K n/a -698.9K -107.42K 45.32K
Financial Cash Flow
1.31M -29.46K 15.48K -150.47K -270.35K -84.09K -6.9M 20.05M 196.53K 186.53K -36.06M 498.6K 5.01M 107.31K n/a 42.77M 3.16M 45.32K
Net Cash Flow
895.12K -495.44K -880.59K -2.37M -561.86K -4.32M -13.09M 19.66M 5.3K -11.41K -108.2K -14.53K 3.77M -157.14K -293.3K 761.15K -33.48K 44.5K
Free Cash Flow
-414.88K -465.98K -896.07K -2.22M -291.51K -4.23M -11.27M -275.19K -212.67K -275.72K -108.2K -513.13K -926.67K -107.31K -293.3K -15.98K -6.05K -819